For decades, chronic disease management in Medicare has been hampered by a fee-for-service payment system that rewards volume and activity rather than true clinical improvement. This model created ...
In this Super IPO 2.0 review, I break down Altucher’s thesis so you can decide whether his approach is worth a closer look.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback